Skip to main content
OpenTrials
Completed

NCT Number: NCT04184388

Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Cognitive Function

This study was the evaluate the efficacy and safety of hydrolysed red ginseng extract on the improvement of Cognitive Function

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cognitive Function

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Department of Psychiatry, Chonbuk National University Hospital

Jeonju, Jeollabuk-do, 54907, South Korea

About this study

This study was 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate. 100 subjects participated in hydrolysed red ginseng extract or placebo group. To evaluate the changes in the evaluation items when hydrolysed red ginseng extract was taken 12 weeks compared with placebo.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Persons who are at least 60 years of age at screening
  • Persons who have Korean Mini-Mental Status Examination(K-MMSE) result in 25-28 points
  • Persons who agree to voluntary participation and to comply with the Notice after fully hearing and understanding the details of this human trial

Exclusion criteria

  • Patients with a past history of treatment with Axis I disorder in SCID(Structured Clinical Interview for DSM-IV) which is a structured clinical interview in the Diagnostic and Statistical Manual of Mental Disorders at Screening or who have been treated within the last 3 years
  • Patients with BMI(Body Mass Index)<18.5 kg/m^ or 35 kg/m^≤BMI(Body Mass Index)
  • Patients with alcohol abuse or dependence within the last 3 months
  • Patients who have clinically significant following severe illness (i.e., Cardiovascular, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric, musculoskeletal, inflammatory, blood and tumors, gastrointestinal diseases, etc.)
  • Patients with a history of clinically significant hypersensitivity to ginseng or red ginseng
  • Patients taking medicines, health functional foods or herbal medicines related to the improvement of cognitive function and memory within 1 month before screening
  • Patients who ingested ginseng and red ginseng extract's health functional food within 1 month before screening
  • Patients who whole blood donation within 1 months before the first ingestion or Component blood donation within 2 weeks
  • Patients who participate in another human trial within 3 months
  • Those who show the following results in the Laboratory test
  • AST, ALT > 3 times upper limit of the normal range
  • Other significant laboratory test opinion
  • Patients who are deemed unsuitable for participating in the human trial due to other reasons

Treatment and study plan

Hydrolysed Red Ginseng Extract

Dietary Supplement

once a day for 1 p.o., after breakfast(10 ml/day, Hydrolysed Red Ginseng extract for 1g/day) for 12 week

Placebo

Dietary Supplement

once a day for 1 p.o., after breakfast(10 ml/day, Hydrolysed Red Ginseng extract for 0g/day) for 12 week

Primary outcomes

  1. Visual learning test

    Time frame: 12 weeks

    Visual learning test was measured in baseline and 12 week.

  2. Visual working memory test

    Time frame: 12 weeks

    Visual working memory test was measured in baseline and 12 week.

  3. MoCA-K; Korean Version of the Montreal Cognitive Assessment

    Time frame: 12 weeks

    Korean Version of the Montreal Cognitive Assessment(MoCA-K) was measured in baseline and 12 week. The cognitive function evaluation using the Montreal Cognitive Assessment(MoCA-K) is a total of 8 items, and evaluates cognitive functions such as time / execution power, vocabulary, memory, attention, sentence, abstraction, delayed recall, and orientation.

    Time / execution power's total score is 5 points, vocabulary's total score is 3 points, attention's total score is 3 points, sentence's total score is 3 points, abstraction's total score is 2 points, delayed recall's total score is 5 points, orientation's total score is 6 points. It takes about 10 minutes to complete, and the total score is 30 points and total score make sum score. A score of 23 points or more is regarded as normal. If you have less than 6 years of education, add 1 point.

Secondary outcomes

  1. Auditory continuous performance test

    Time frame: 12 weeks

    Auditory continuous performance test was measured in baseline and 12 week.

  2. Verbal learning test

    Time frame: 12 weeks

    Verbal learning test was measured in baseline and 12 week.

  3. PSS; Perceived stress scale

    Time frame: 12 weeks

    Perceived stress scale(PSS) was measured in baseline and 12 week. It consists of 10 questions. Each question is evaluated from 0 (none) to 4 (very often), and 4 items (4, 5, 7, 8) are scored back and added to the remaining questions. The duration of the last month should be presented before implementation (if the duration is longer, the predictability is lowered).

  4. BDI; Beck Depression Inventory

    Time frame: 12 weeks

    Beck Depression Inventory(BDI) was measured in baseline and 12 week. It consists of 21 items including cognitive, emotional, synchronous, and physical symptoms of depression. The total score ranges from 0~63 points for each question. Beck Depression Inventory(BDI) score is 0 ~ 9 points non-depression, 10 ~ 15 is mild depression, 16 ~ 23 is moderate depression, and 24 ~ 63 is severe depression.

  5. BDNF; Brain-derived neurotrophic factor

    Time frame: 12 weeks

    Brain-derived neurotrophic factor(BDNF)(pg/mL) was measured in baseline and 12 week.

  6. TAS(Total antioxidant status)

    Time frame: 12 weeks

    Total antioxidant status(TAS) was measured in baseline and 12 week.

Sponsors and collaborators

Lead sponsor

Chonbuk National University Hospital

Other

Registry information

Official study title

A 12 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Hydrolysed Red Ginseng Extract on Improvement of Cognitive Function

Important dates

Study start
2019
Primary completion
2020
Study completion
2020
First posted
Dec 3, 2019
Registry last updated
Jan 27, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.